Author
Listed:
- Mohamed Elgendy
(European Institute of Oncology, IEO)
- Marco Ciro
(European Institute of Oncology, IEO
IFOM (Fondazione Istituto FIRC di Oncologia Molecolare) at the IFOM–European Institute of Oncology (IEO) Campus)
- Amal Kamal Abdel-Aziz
(European Institute of Oncology, IEO
Present address: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt)
- Giuseppe Belmonte
(University of Siena)
- Roberto Dal Zuffo
(European Institute of Oncology, IEO)
- Ciro Mercurio
(European Institute of Oncology, IEO)
- Clelia Miracco
(University of Siena)
- Luisa Lanfrancone
(European Institute of Oncology, IEO)
- Marco Foiani
(IFOM (Fondazione Istituto FIRC di Oncologia Molecolare) at the IFOM–European Institute of Oncology (IEO) Campus
University of Milan)
- Saverio Minucci
(European Institute of Oncology, IEO
University of Milan
Drug Development Program, European Institute of Oncology, IEO)
Abstract
Mcl-1 is a unique Bcl-2 family member that plays crucial roles in apoptosis. Apoptosis-unrelated functions of Mcl-1 are however emerging, further justifying its tight regulation. Here we unravel a novel mechanism of Mcl-1 regulation mediated by the haplo-insufficient tumour suppressor Beclin 1. Beclin 1 negatively modulates Mcl-1 stability in a reciprocal manner whereby depletion of one leads to the stabilization of the other. This co-regulation is independent of autophagy and of their physical interaction. Both Beclin 1 and Mcl-1 are deubiquitinated and thus stabilized by binding to a common deubiquitinase, USP9X. Beclin 1 and Mcl-1 negatively modulate the proteasomal degradation of each other through competitive displacement of USP9X. The analysis of patient-derived melanoma cells and tissue samples shows that the levels of Beclin 1 decrease, while Mcl-1 levels subsequently increase during melanoma progression in a significant inter-dependent manner. The identified inverse co-regulation of Beclin 1 and Mcl-1 represents a mechanism of functional counteraction in cancer.
Suggested Citation
Mohamed Elgendy & Marco Ciro & Amal Kamal Abdel-Aziz & Giuseppe Belmonte & Roberto Dal Zuffo & Ciro Mercurio & Clelia Miracco & Luisa Lanfrancone & Marco Foiani & Saverio Minucci, 2014.
"Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner,"
Nature Communications, Nature, vol. 5(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6637
DOI: 10.1038/ncomms6637
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6637. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.